Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: This study is classified as reliable without restrictions because it was carried out in a method equivalent/similar to OECD TG 401.
Justification for type of information:
Read across justification included in Section 13
Cross-reference
Reason / purpose for cross-reference:
read-across: supporting information
Reference
Endpoint:
acute toxicity: oral
Type of information:
read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: This study is classified as reliable without restrictions because it was carried out in a method equivalent/similar to OECD TG 401.
Justification for type of information:
Read across justification included in Section 13
Reason / purpose for cross-reference:
read-across source
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
GLP compliance:
yes
Test type:
standard acute method
Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Route of administration:
oral: gavage
Vehicle:
other: Undiluted
Doses:
Single dose level of 5000 mg/kg
No. of animals per sex per dose:
Five
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 5 000 mg/kg bw

No deaths resulted. Main clinical signs were hypoactivity, excess salivation, diarrhoea, urine-stained abdomen and hair loss around the anal area. At necropsy, the only visible finding was kidney distension in one male animal.

Interpretation of results:
not classified
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
The LD50 was greater than 5000 mg/kg.
Executive summary:

The acute oral toxicity of hydrodesulfurised kerosine was studied in 5 male and 5 female albino Sprague-Dawley rats. Animals weighing 188-330g received a single dose of 5000 mg/kg by oral gavage and were observed for clinical signs and mortality at hourly intervals during the first 6 hours after administration. Thereafter animals were observed twice daily for 14 days. At termination of the study, all animals were sacrificed and subjected to gross necropsy examination. Clinical signs observed throughout the study include hypoactivity, excess salivation, diarrhoea, urine stained abdomen and hair loss around the anal area. No mortality was observed. The LD50 for hydrodesulfurised kerosine was > 5000 mg/kg.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1982
Report date:
1982

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
GLP compliance:
yes
Test type:
standard acute method

Test material

Constituent 1
Reference substance name:
Kerosine (petroleum), hydrodesulfurized
EC Number:
265-184-9
EC Name:
Kerosine (petroleum), hydrodesulfurized
Cas Number:
64742-81-0
IUPAC Name:
Kerosine (petroleum), hydrodesulfurized
Constituent 2
Reference substance name:
Hydrodesulfurised kerosine
IUPAC Name:
Hydrodesulfurised kerosine
Test material form:
other: low viscosity liquid hydrocarbon
Details on test material:
- Name of test material (as cited in study report): Hydrodesulfurised kerosine, CAS No. 64742-81-0
- Lot/batch No.: API 81-07

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
other: Undiluted
Doses:
Single dose level of 5000 mg/kg
No. of animals per sex per dose:
Five

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 5 000 mg/kg bw

Any other information on results incl. tables

No deaths resulted. Main clinical signs were hypoactivity, excess salivation, diarrhoea, urine-stained abdomen and hair loss around the anal area. At necropsy, the only visible finding was kidney distension in one male animal.

Applicant's summary and conclusion

Interpretation of results:
not classified
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
The LD50 was greater than 5000 mg/kg.
Executive summary:

The acute oral toxicity of hydrodesulfurised kerosine was studied in 5 male and 5 female albino Sprague-Dawley rats. Animals weighing 188-330g received a single dose of 5000 mg/kg by oral gavage and were observed for clinical signs and mortality at hourly intervals during the first 6 hours after administration. Thereafter animals were observed twice daily for 14 days. At termination of the study, all animals were sacrificed and subjected to gross necropsy examination. Clinical signs observed throughout the study include hypoactivity, excess salivation, diarrhoea, urine stained abdomen and hair loss around the anal area. No mortality was observed. The LD50 for hydrodesulfurised kerosine was > 5000 mg/kg.